EZH2 and hepatocellular carcinoma: Importantly, PANDA and CDKN1A downregulation was independent of P53 mutational status in HCC indicating that there is positive selective pressure for low PANDA and CDKN1A and elevated SAFA, BMI1 and EZH2 expression levels.